Zurich Cantonal Bank’s Acorda Therapeutics ACOR Stock Holding History

Zurich Cantonal Bank’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-15	Closed	-$5K	–	2639
2019 Q3	$5K	Hold	15	–	–	﹤0.01%	2599
2019 Q2	$14K	Hold	15	–	–	﹤0.01%	2539
2019 Q1	$24K	Sell	15 -11	-42%	-$19.8K	﹤0.01%	2369
2018 Q4	$48K	Hold	26	–	–	﹤0.01%	2060
2018 Q3	$61K	Hold	26	–	–	﹤0.01%	2035
2018 Q2	$88K	Sell	26 -4	-13%	-$12.2K	﹤0.01%	1728
2018 Q1	$86K	Hold	30	–	–	﹤0.01%	1687
2017 Q4	$78K	Buy	30 +6	+25%	+$17.1K	﹤0.01%	1733
2017 Q3	$69K	Hold	24	–	–	﹤0.01%	1608
2017 Q2	$58K	Hold	24	–	–	﹤0.01%	1675
2017 Q1	$61K	Hold	24	–	–	﹤0.01%	1642
2016 Q4	$55K	Buy	24 +14	+140%	+$33.3K	﹤0.01%	1654
2016 Q3	$26K	Buy	10 +2	+25%	+$5.97K	﹤0.01%	2130
2016 Q2	$25K	Hold	8	–	–	﹤0.01%	1938
2016 Q1	$26K	Hold	8	–	–	﹤0.01%	1849
2015 Q4	$42K	Buy	8 +4	+100%	+$17.5K	﹤0.01%	1539
2015 Q3	$13K	Buy	4 +2	+100%	+$7.76K	﹤0.01%	1757
2015 Q2	$6K	Hold	2	–	–	﹤0.01%	1828
2015 Q1	$6K	Buy	+2	New	+$9.16K	﹤0.01%	1786
2014 Q1	–	Sell	-83	Closed	-$292K	–	1000
2013 Q4	$292K	Hold	83	–	–	0.01%	771
2013 Q3	$343K	Buy	+83	New	+$358K	0.01%	714

Other funds holding ACOR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Zurich Cantonal Bank's ACOR Position: Q4 2019 in Review

Zurich Cantonal Bank sold out of Acorda Therapeutics (ACOR) in Q4 2019, closing a stake of 15 shares — an estimated $5K sold.

Zurich Cantonal Bank first reported a position in ACOR in Q3 2013 and held it in 21 quarters. The position peaked at $343K in Q3 2013. 121 funds tracked by Wall St. Rank hold ACOR as of Q4 2019.

Zurich Cantonal Bank reported no remaining Acorda Therapeutics position as of Q4 2019 after selling out during the quarter.
Zurich Cantonal Bank sold 15 Acorda Therapeutics shares in Q4 2019, an estimated $5K.
Zurich Cantonal Bank first reported a position in Acorda Therapeutics in Q3 2013 and held it in 21 quarters.
Zurich Cantonal Bank's Acorda Therapeutics position peaked at $343K in Q3 2013.
121 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2019.

Based on Zurich Cantonal Bank's 13F filing for Q4 2019, filed 21 Jan 2020.